Take a step back and look at the secondary market offerings like Twitter.
A company with a speculative run-up and no business model is very high risk. Also, the limiting reagent in secondary market trading is investor count. At 500, the company has to go public, so many companies contractually limit secondary sales to avoid the additional reporting requirements.
A company with a speculative run-up and no business model is very high risk. Also, the limiting reagent in secondary market trading is investor count. At 500, the company has to go public, so many companies contractually limit secondary sales to avoid the additional reporting requirements.